Essential hypertension: effect of an oral inhibitor of angiotensin-converting enzyme.
G. A. MacGregor, Julia C. Jones(University College Dublin), Nirmala D. Markandu(University of London), J E Roulston(Charing Cross Hospital)
Cited by 73
Related Papers
Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies
|The Lancet Diabetes & Endocrinology|2018|340
DOUBLE-BLIND STUDY OF THREE SODIUM INTAKES AND LONG-TERM EFFECTS OF SODIUM RESTRICTION IN ESSENTIAL HYPERTENSION
|The Lancet|1989|272
Structural Skin Capillary Rarefaction in Essential Hypertension
|Hypertension|1999|259